⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9548196 | 0.83 | KDM4E (0.72) | — | |
| SCHEMBL3456275 | 0.79 | MAPT (0.47) | — | |
| SCHEMBL1144592 | 0.79 | ALDH1A1 (0.47) | — | |
| SCHEMBL17629580 | 0.79 | KDM4E (0.51) | — | |
| SCHEMBL5608026 | 0.78 | KDM4E (0.59) | — | |
| Hydrochloric Acid SCHEMBL7360757 | 0.78 | MAPT (0.46) | — | |
| SCHEMBL14079850 | 0.78 | ALDH1A1 (0.46) | — | |
| SCHEMBL21847505 | 0.78 | MAPT (0.46) | — | |
| SCHEMBL7588914 | 0.77 | KDM4E (0.59) | — | |
| SCHEMBL15247080 | 0.77 | KDM4E (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0533832-B1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | US SECRETARY UNITED STATES DEP (US) | 2002-11-20 | — | — | EP | disclosed |
| EP-0533832-A4 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | US COMMERCE (US) | 1993-04-28 | — | — | EP | disclosed |
| EP-0533832-A1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5086072-A | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-02-04 | — | — | US | disclosed |
| WO-1991019493-A1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1991-12-26 | — | — | WO | disclosed |